Vanguard Total Stock Market ETF at week 10 of a buy setup, +10.43% performance since entry. All 3 statistical targets of our model have been hit: the calculated coverage ends here, but the residual 40% can run on with a managed stop — trade setup and technical analysis below.

A buy setup now at week 10, with all 3 statistical targets already hit and a performance of 8.75% since entry. The stop is at breakeven — risk is zeroed out. Technical analysis suggests managing the residual capital with the Inversion Point as a trailing reference.

Vertex Pharmaceuticals weekly technical analysis — fresh buy setup, week 1. Double bottom in the 421 area, bullish MACD crossover, strong support cluster in the 444 area. IQS at 60, medium signal strength — steady trade setup requiring active management.

Vertiv weekly technical analysis — sell signal at week 3, no confirmation yet. Trade setup remains inconclusive; performance at -5.5% from inception. Our model flags elevated-risk conditions with the stock 168% above its 200-week moving average.

Week 23 for Valero Energy: all 3 model time windows completed, +27.5% performance. Residual capital runs on a trailing stop anchored to the weekly Inversion Point. Tough week: -8.6% with sellers at 78%. The daily double bottom in the 230 area is the key level to watch.

Vanguard Dividend Appreciation ETF buy setup at week 10, +6.2% performance since entry. All 3 statistical targets of our most advanced model have been hit — the trade now moves to residual capital management with a trailing stop on the Inversion Point.